Article Text

PDF
Cardiac resynchronisation therapy in patients with chronic heart failure
  1. Gautam G Lalani,
  2. Ulrika Birgersdotter-Green
  1. University of California, San Diego, California, USA
  1. Correspondence to Dr Ulrika Birgersdotter-Green, University of California, San Diego, 9300 Campus Point Drive, #7411, San Diego, CA 92037, USA; ubgreen{at}ucsd.edu

Abstract

Cardiac resynchronisation therapy (CRT) is common treatment for congestive heart failure (HF) with decreased LV function and wide QRS complex. Its foundations are set in the understanding of the pathophysiology of ventricular dyssynchrony. Over the last several decades, CRT has evolved through changes in implantation techniques, device and lead design, imaging modalities and our growing clinical experience. This review article will discuss the vast clinical experience that has led to current guidelines recommendations for CRT in patients with mild-to-severe HF. In addition, the article will also discuss recent evidence of benefits of CRT in patients beyond the guidelines. The article will also address the issue of non-responders, optimisation of CRT, postimplant evaluation and remote monitoring.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.